Back to search results

Group Cognitive Behavior Sessions to Decrease Distress in Cancer Patients

This study is testing how well group Cognitive Behavioral Cancer Stress Management (CBCSM) sessions can help reduce psychological distress in people with cancer. CBCSM teaches you ways to manage the stress that comes with a cancer diagnosis and treatment. You might be able to join if you are 18 or older, have a cancer diagnosis (hematopoietic and lymphoid system neoplasm, malignant solid neoplasm, or metastatic malignant solid neoplasm) with a predicted survival of more than one year, and have experienced cancer treatment within the last year or are planning treatment. The study aims to see if these sessions can lower your post-traumatic stress (PTS) scores over 12 months. The study plans to enroll 400 participants, but its current status is unclear.

Study design
This interventional study plans to enroll 400 participants and assigns them to one of two groups. One group participates in CBCSM group sessions, while the other group completes questionnaires only.
What's involved
If you are in Group I, you will participate in five CBCSM group sessions and complete questionnaires throughout the trial and during follow-up at 1, 3, 6, and 12 months. If you are in Group II, you will complete questionnaires throughout the trial and during follow-up at 1, 3, 6, and 12 months.
Compensation
Not stated in the trial record.
Follow-up
Participants are followed for 12 months after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06015932

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

Recruiting
NAAges 18+InterventionalSupportive care
Mayo Clinic
~400 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:Cognitive Behavior TherapyQuestionnaire Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in post-traumatic stress (PTS) score
Measured over At baseline, 1, 3, 6, and 12 months

Conditions

Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm

Explore related trials

Hematologic NeoplasmSolid Neoplasm

NCT06015932

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Mayo Clinic in Rochester

    Rochester, Minnesotastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Shawna L. Ehlers, Ph.D., L.P. · PRINCIPAL_INVESTIGATOR · Mayo Clinic in Rochester

Who to contact

Clinical Trials Referral Office
[email protected]
855-776-0015
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Eligible for the cognitive behavioral cancer stress management (CBCSM) clinical service
Cancer diagnosis with predicted survival \> 1 year
Cancer treatment within past 1 year or treatment planning in progress
Age \>= 18-years
Moderate distress screen, indicated by Impact of Event Scale-Revised (IES-R) score \>= 14 or clinical judgment
Written informed research consent

Exclusion

Inability to actively participate in and learn from group therapy (e.g., psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgment in clinical consultation (Individual therapy or alternative group therapy will be offered)

What this trial measures

  • Change in post-traumatic stress (PTS) scoreAt baseline, 1, 3, 6, and 12 months

    Each item on the PTS is rated on a 5-point scale (0=Not at all; 1=A little bit; 2=Moderately; 3=Quite a bit, and 4=Extremely). The total score can range from 0 to 36 with higher scores indicating greater severity of posttraumatic stress disorder.